Variant report

Variant	esv3373072
Chromosome Location	chr21:47397324-47398672
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:14)
CpG islands
(count:61)
Chromatin interactive
region (count:3)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:14 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr21:47397006-47397624	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr21:47397460-47397610	HA-sp	spinal cord:	n/a	n/a
3	CTCF	chr21:47397380-47397530	AG04449	skin:	n/a	n/a
4	CTCF	chr21:47397406-47397463	H1-hESC	embryonic stem cell:	n/a	n/a
5	EP300	chr21:47397228-47397714	ECC-1	luminal epithelium:	n/a	n/a
6	MAZ	chr21:47397323-47398871	IMR90	lung:	n/a	chr21:47398447-47398456
7	MAZ	chr21:47398161-47398490	K562	blood:	n/a	chr21:47398447-47398456
8	RAD21	chr21:47397469-47397580	H1-hESC	embryonic stem cell:	n/a	n/a
9	REST	chr21:47397438-47397662	SK-N-SH	brain:	n/a	n/a
10	SIN3A	chr21:47396968-47397640	H1-hESC	embryonic stem cell:	n/a	chr21:47397312-47397320
11	TBP	chr21:47397397-47397555	H1-hESC	embryonic stem cell:	n/a	n/a
12	USF2	chr21:47397456-47397475	H1-hESC	embryonic stem cell:	n/a	n/a
13	ZNF143	chr21:47396982-47397994	H1-hESC	embryonic stem cell:	n/a	n/a
14	ZNF263	chr21:47398040-47398688	HEK293-T-REx	kidney:	n/a	chr21:47398303-47398324 chr21:47398261-47398282

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:47398596-47398646	K562	blood:	n/a
2	chr21:47398596-47398646	AG09319	gingival:	n/a
3	chr21:47398596-47398646	SK-N-SH	brain:	n/a
4	chr21:47398596-47398646	AG09309	skin:	n/a
5	chr21:47398596-47398646	GM12892	blood:	n/a
6	chr21:47398596-47398646	BE2_C	brain:	n/a
7	chr21:47398596-47398646	A549	lung:	n/a
8	chr21:47398596-47398646	GM12891	blood:	n/a
9	chr21:47398596-47398646	HEEpiC	esophagus:	n/a
10	chr21:47398596-47398646	NB4	blood:	n/a
11	chr21:47398596-47398646	SAEC	small airway:	n/a
12	chr21:47398596-47398646	HCM	heart:	n/a
13	chr21:47398596-47398646	NT2-D1	testis:	n/a
14	chr21:47398596-47398646	AG04450	lung:	fetal
15	chr21:47398596-47398646	PFSK-1	brain:	n/a
16	chr21:47398596-47398646	HNPCEpiC	eye:	n/a
17	chr21:47398596-47398646	GM19239	blood:	n/a
18	chr21:47398596-47398646	HCPEpiC	choroid plexus:	n/a
19	chr21:47398596-47398646	H1-hESC	embryonic stem cell:	embryo
20	chr21:47398596-47398646	ECC-1	luminal epithelium:	n/a
21	chr21:47398596-47398646	Caco-2	colon:	n/a
22	chr21:47398596-47398646	HUVEC	blood vessel:	n/a
23	chr21:47398596-47398646	HIPEpiC	eye:	n/a
24	chr21:47398596-47398646	LNCaP	prostate:	n/a
25	chr21:47398596-47398646	PrEC	prostate:	n/a
26	chr21:47398596-47398646	HepG2	liver:	n/a
27	chr21:47398596-47398646	ovcar-3	ovarian:	n/a
28	chr21:47398596-47398646	HRE	kidney:	n/a
29	chr21:47398596-47398646	GM12878	blood:	n/a
30	chr21:47398596-47398646	SKMC	muscle:	n/a
31	chr21:47398596-47398646	AG04449	skin:	fetal
32	chr21:47398596-47398646	Hepatocyte	liver:	n/a
33	chr21:47398596-47398646	AoSMC	blood vessel:	n/a
34	chr21:47398596-47398646	HCF	heart:	n/a
35	chr21:47398596-47398646	AG10803	skin:	n/a
36	chr21:47398596-47398646	HRCEpiC	kidney:	n/a
37	chr21:47398596-47398646	HAEpiC	amniotic membrane:	n/a
38	chr21:47398596-47398646	SK-N-SH_RA	brain:	n/a
39	chr21:47398596-47398646	T-47D	breast:	n/a
40	chr21:47398596-47398646	IMR90	lung:	fetal
41	chr21:47398596-47398646	HPAEpiC	pulmonary alveolar:	n/a
42	chr21:47398596-47398646	MCF10A-Er-Src	breast:	n/a
43	chr21:47398596-47398646	CMK	blood:	n/a
44	chr21:47398596-47398646	HCT-116	colon:	n/a
45	chr21:47398596-47398646	PANC-1	pancreas:	n/a
46	chr21:47398596-47398646	SK-N-MC	brain:	n/a
47	chr21:47398596-47398646	NH-A	brain:	n/a
48	chr21:47398596-47398646	Jurkat	blood:	n/a
49	chr21:47398596-47398646	HL-60	blood:	n/a
50	chr21:47398596-47398646	GM06990	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:47388213..47390098-chr21:47396842..47399384,2	MCF-7	breast:
2	chr21:47393205..47395473-chr21:47397498..47399697,5	K562	blood:
3	chr21:47384997..47386531-chr21:47397126..47399086,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-COL6A1-4	chr21:47398531-47398625	NONHSAT083005
2	lnc-FTCD-2	chr21:47397451-47397653	XLOC_014129

No data

Variant related genes	Relation type
COL6A1	TF binding region
COL6A1	CpG island
AFF4	miRNA target sites

Extended variants
information (count: 52 )
Associated
traits (count: 36 )

Variant overlapped rSNPs/rCNVs (count:52 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs538168549	chr21:47397356-47397357	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs531219126	chr21:47397395-47397396	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs557691322	chr21:47397400-47397401	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs186906097	chr21:47397415-47397416	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs191198357	chr21:47397468-47397469	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs7275644	chr21:47397525-47397526	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs546794334	chr21:47397555-47397556	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs1883048	chr21:47397586-47397587	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs571878911	chr21:47397588-47397589	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs538390005	chr21:47397590-47397591	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs556526149	chr21:47397622-47397623	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs77215405	chr21:47397722-47397723	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs78615502	chr21:47397724-47397725	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs9980553	chr21:47397727-47397728	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs76573695	chr21:47397729-47397730	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs9979446	chr21:47397735-47397736	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs151233285	chr21:47397773-47397774	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs568790032	chr21:47397805-47397806	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs117775279	chr21:47397828-47397829	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
20	rs117179421	chr21:47397867-47397868	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs200825536	chr21:47398001-47398002	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs373986375	chr21:47398058-47398059	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs567961613	chr21:47398096-47398097	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs573099935	chr21:47398111-47398112	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs533825716	chr21:47398117-47398118	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs11910769	chr21:47398149-47398150	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs11910668	chr21:47398152-47398153	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs11910685	chr21:47398162-47398163	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs114041923	chr21:47398192-47398193	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs114606768	chr21:47398193-47398194	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs540380110	chr21:47398232-47398233	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs189709475	chr21:47398288-47398289	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs555903812	chr21:47398314-47398315	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs377064560	chr21:47398378-47398379	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs578136906	chr21:47398390-47398391	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs139685046	chr21:47398391-47398392	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs113410831	chr21:47398392-47398393	Weak transcription Enhancers ZNF genes & repeats Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs386819384	chr21:47398410-47398411	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs9983378	chr21:47398411-47398412	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs112613881	chr21:47398414-47398415	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs562060468	chr21:47398500-47398501	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs182747237	chr21:47398517-47398518	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs58714612	chr21:47398527-47398528	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs527673367	chr21:47398533-47398534	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs539314995	chr21:47398564-47398565	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs144559465	chr21:47398577-47398578	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs368232374	chr21:47398610-47398611	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs146622046	chr21:47398616-47398617	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs568947657	chr21:47398617-47398618	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs386819385	chr21:47398647-47398648	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:36)

Disease	PMID	Source
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Breast cancer	17899364	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:164 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:47392400-47397600	Active TSS	iPS-15b Cell Line	embryonic stem cell
2	chr21:47392800-47397600	Active TSS	HUES48 Cell Line	embryonic stem cell
3	chr21:47394400-47400400	Weak transcription	Pancreatic Islets	Pancreatic Islet
4	chr21:47394800-47400800	Weak transcription	Pancreas	Pancrea
5	chr21:47395000-47397400	Active TSS	HUES6 Cell Line	embryonic stem cell
6	chr21:47395000-47398400	Weak transcription	Brain Substantia Nigra	brain
7	chr21:47395000-47400600	Weak transcription	Dnd41	blood
8	chr21:47395000-47401000	Enhancers	Fetal Muscle Leg	muscle
9	chr21:47395200-47400600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr21:47395200-47400800	Weak transcription	Left Ventricle	heart
11	chr21:47395200-47401000	Weak transcription	Gastric	stomach
12	chr21:47395200-47401000	Weak transcription	HSMMtube	muscle
13	chr21:47395400-47397400	Weak transcription	NHDF-Ad	bronchial
14	chr21:47395400-47398000	Weak transcription	Fetal Heart	heart
15	chr21:47395400-47398200	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr21:47395400-47398200	Weak transcription	Osteobl	bone
17	chr21:47395400-47398400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr21:47395400-47398600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr21:47395400-47400600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
20	chr21:47395400-47400600	Weak transcription	Adipose Nuclei	Adipose
21	chr21:47395400-47400800	Weak transcription	Right Atrium	heart
22	chr21:47395400-47400800	Weak transcription	HSMM	muscle
23	chr21:47395400-47401000	Weak transcription	HMEC	breast
24	chr21:47395600-47397400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr21:47395600-47397400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr21:47395600-47397400	Weak transcription	NH-A	brain
27	chr21:47395600-47397400	Weak transcription	NHLF	lung
28	chr21:47395600-47401000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr21:47395800-47397800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr21:47396200-47397400	Weak transcription	Colon Smooth Muscle	Colon
31	chr21:47396600-47397400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr21:47396600-47397400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
33	chr21:47396600-47397400	Enhancers	Fetal Stomach	stomach
34	chr21:47396600-47397400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
35	chr21:47396600-47397600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
36	chr21:47396600-47397600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
37	chr21:47396600-47397600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
38	chr21:47396600-47397600	Bivalent Enhancer	Fetal Intestine Small	intestine
39	chr21:47396600-47397600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
40	chr21:47396600-47398600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr21:47396600-47399200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr21:47396600-47400600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr21:47396800-47397400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr21:47396800-47397600	Active TSS	H9 Cell Line	embryonic stem cell
45	chr21:47396800-47397600	Active TSS	HUES64 Cell Line	embryonic stem cell
46	chr21:47396800-47397600	Active TSS	iPS-20b Cell Line	embryonic stem cell
47	chr21:47396800-47398400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
48	chr21:47396800-47399200	Weak transcription	Placenta Amnion	Placenta Amnion
49	chr21:47397000-47397600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr21:47397000-47397600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links